Literature DB >> 22306263

CUX1 transcription factors: from biochemical activities and cell-based assays to mouse models and human diseases.

Laura Hulea1, Alain Nepveu.   

Abstract

ChIP-chip and expression analyses indicated that CUX1 transcription factors regulate a large number of genes and microRNAs involved in multiple cellular processes. Indeed, in proliferating cells CUX1 was shown to regulate several genes involved in DNA replication, progression into S phase and later, the spindle assembly checkpoint that controls progression through mitosis. siRNA-mediated knockdown established that CUX1 is required for cell motility. Moreover, higher expression of short CUX1 isoforms, as observed in many cancers, was shown to stimulate cell migration and invasion. In parallel, elevated expression particularly in higher grade tumors of breast and pancreatic cancers implicated CUX1 in tumor initiation and progression. Indeed, transgenic mouse models demonstrated a causal role of CUX1 in cancers originating from various cell types. These studies revealed that higher CUX1 expression or activity not only stimulates cell proliferation and motility, but also promotes genetic instability. CUX1 has also been implicated in the etiology of polycystic kidney diseases, both from a transgenic approach and the analysis of CUX1 activity in multiple mouse models of this disease. Studies in neurobiology have uncovered a potential implication of CUX1 in cognitive disorders, neurodegeneration and obesity. CUX1 was shown to be expressed specifically in pyramidal neurons of the neocortex upper layers where it regulates dendrite branching, spine development, and synapse formation. In addition, modulation of CUX1 expression in neurons of the hypothalamus has been associated with changes in leptin receptor trafficking in the vicinity of the primary cilium resulting in altered leptin signaling and ultimately, eating behavior. Overall, studies in various fields have allowed the development of several cell-based assays to monitor CUX1 function and have extended the range of organs in which CUX1 plays an important role in development and tissue homeostasis.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22306263     DOI: 10.1016/j.gene.2012.01.039

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  31 in total

1.  Impact of CUX2 on the female mouse liver transcriptome: activation of female-biased genes and repression of male-biased genes.

Authors:  Tara L Conforto; Yijing Zhang; Jennifer Sherman; David J Waxman
Journal:  Mol Cell Biol       Date:  2012-09-10       Impact factor: 4.272

2.  Controlled expression of Drosophila homeobox loci using the Hostile takeover system.

Authors:  Naureen Javeed; Nicholas J Tardi; Maggie Maher; Swetha Singari; Kevin A Edwards
Journal:  Dev Dyn       Date:  2015-06       Impact factor: 3.780

3.  DNA methylation and obesity traits: An epigenome-wide association study. The REGICOR study.

Authors:  Sergi Sayols-Baixeras; Isaac Subirana; Alba Fernández-Sanlés; Mariano Sentí; Carla Lluís-Ganella; Jaume Marrugat; Roberto Elosua
Journal:  Epigenetics       Date:  2017-11-27       Impact factor: 4.528

Review 4.  Epidemiological and genetic clues for molecular mechanisms involved in uterine leiomyoma development and growth.

Authors:  Arno E Commandeur; Aaron K Styer; Jose M Teixeira
Journal:  Hum Reprod Update       Date:  2015-07-03       Impact factor: 15.610

5.  Upregulated Expression of CUX1 Correlates with Poor Prognosis in Glioma Patients: a Bioinformatic Analysis.

Authors:  Xiujie Wu; Fan Feng; Chuanchao Yang; Moxuan Zhang; Yanhao Cheng; Yayun Zhao; Yayu Wang; Fengyuan Che; Jian Zhang; Xueyuan Heng
Journal:  J Mol Neurosci       Date:  2019-08-03       Impact factor: 3.444

6.  CUX1 is a haploinsufficient tumor suppressor gene on chromosome 7 frequently inactivated in acute myeloid leukemia.

Authors:  Megan E McNerney; Christopher D Brown; Xiaoyue Wang; Elizabeth T Bartom; Subhradip Karmakar; Chaitanya Bandlamudi; Shan Yu; Jinkyung Ko; Barry P Sandall; Thomas Stricker; John Anastasi; Robert L Grossman; John M Cunningham; Michelle M Le Beau; Kevin P White
Journal:  Blood       Date:  2012-12-03       Impact factor: 22.113

7.  CUX2 protein functions as an accessory factor in the repair of oxidative DNA damage.

Authors:  Ranjana Pal; Zubaidah M Ramdzan; Simran Kaur; Philippe M Duquette; Richard Marcotte; Lam Leduy; Sayeh Davoudi; Nathalie Lamarche-Vane; Angelo Iulianella; Alain Nepveu
Journal:  J Biol Chem       Date:  2015-07-28       Impact factor: 5.157

8.  Targeted pharmacogenetic analysis of antipsychotic response in the CATIE study.

Authors:  Qian Liu; Maidar Jamba; Calvin Patrick; Saranya Padmanabhan; Mark D Brennan
Journal:  Pharmacogenomics       Date:  2012-08       Impact factor: 2.533

Review 9.  CUX1, a haploinsufficient tumour suppressor gene overexpressed in advanced cancers.

Authors:  Zubaidah M Ramdzan; Alain Nepveu
Journal:  Nat Rev Cancer       Date:  2014-09-05       Impact factor: 60.716

10.  Recurrent genetic defects on chromosome 7q in myeloid neoplasms.

Authors:  N Hosono; H Makishima; A Jerez; K Yoshida; B Przychodzen; S McMahon; Y Shiraishi; K Chiba; H Tanaka; S Miyano; M Sanada; I Gómez-Seguí; A K Verma; M A McDevitt; M A Sekeres; S Ogawa; J P Maciejewski
Journal:  Leukemia       Date:  2014-01-16       Impact factor: 11.528

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.